Publications by authors named "L Sternik"
Article Synopsis
- The war that started on October 7, 2023, has led to an unexpected rise in open-heart surgeries at Israel's largest cardiac surgery department, despite half of the surgeons being in military service.
- A study analyzed data from 275 patients who had cardiac surgeries or ECMO during the first two months of the war, comparing it to a similar period in 2022.
- Results showed a 33% increase in open-heart procedures and a significant rise in transplants in 2023, but patient outcomes, including complications and mortality rates, remained consistent with those from 2022.
Surgical Ablation for Atrial Fibrillation: Risk Factors for Recurrence and Long-Term Outcome.
J Cardiothorac Vasc Anesth
September 2024
Article Synopsis
- Atrial fibrillation (AF) is a common heart rhythm disorder, and this study explores the effectiveness of surgical ablation as a treatment option, especially for patients also undergoing other cardiac surgeries.
- The research involved 668 patients who underwent this procedure between 2006 and 2022, assessing their outcomes over multiple years, including recurrence of AF and mortality rates.
- Results showed high success rates for maintaining freedom from AF, with success decreasing slightly over 7 years, while factors like age, female sex, and diabetes were linked to higher risks of recurrence and mortality.
Article Synopsis
- Long-term support with the HeartMate 3 (HM3) left ventricular assist device (LVAD) has improved outcomes for end-stage heart failure patients, but there's limited data on those who had simultaneous cardiac surgeries during the procedure.
- In a study of 131 patients between December 2016 and April 2022, 23 underwent concomitant cardiac surgical procedures (CCSP) while receiving HM3-LVAD, while 108 had only the HM3-LVAD implanted.
- Results showed no significant differences in 30-day, 6-month, and 12-month mortality rates between the CCSP group and the HM3-only group, indicating that simultaneous surgeries do not adversely affect survival when getting an HM3-L
Article Synopsis
- The study analyzed the use of extracorporeal membrane oxygenation (ECMO) in pregnant women experiencing severe respiratory or circulatory failure across 10 hospitals in Israel over three years.
- Out of 540,234 live births, only 28 obstetric patients (5.2 per 100,000 births) were treated with ECMO, primarily for hypoxic respiratory failure due to conditions like ARDS, with COVID-19 being a significant factor.
- Despite the low incidence, ECMO resulted in high survival rates for both mothers (89.3%) and babies (100%), with complications being rare.